Frequently Asked Questions
The market is segmented based on , By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Other Technologies), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery and Development, Other Applications), Product and Service (Reagents and Consumables), End User (Pharmaceutical and Biopharmaceutical Industry, Biotechnology Industry, Academic Institutions, CROs, Government Research Organizations, Others), Method (Ex-Vivo, In-Vivo) – Industry Trends and Forecast to 2030.
.
The Global Genome Editing Market size was valued at USD 5512.13 USD Million in 2022.
The Global Genome Editing Market is projected to grow at a CAGR of 17.2% during the forecast period of 2023 to 2030.
The major players operating in the market include Merck KGaA, GenScript, Sangamo Therapeutics, Lonza, Editas Medicine, CRISPR Therapeutics, Tecan Trading AG, Precision Biosciences, PerkinElmer , Cellectis S.A, Genome Medical, BioMed Central Ltd, Aevi Genomic Medicine, Congenica Ltd, Deep Genomics, Illumina , Thermo Fisher Scientific , QIAGEN N.V, Agilent Technologies , BioRad Laboratories .
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina, and Rest of South America as part of South America.
